Taken together with our transcriptional profiling showing enrichment for Tet2 and Kmt2d deficient signatures, these data suggest that reduced levels of Smc3 in lymphomas impairs expression and functionality of tumor suppressor genes through disruption of enhancer-promoter interactions. The gene discussed is KMT2D; the disease is neoplasm.